Product
Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine
Aliases
Diphtheria,Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed
3 clinical trials
4 indications
Indication
Healthy Control ParticipantsIndication
PertussisIndication
DiphtheriaIndication
TetanusClinical trial
A Phase III, Single Center, Randomized, Blind, and Positive Control Clinical Trial to Evaluate the Immunogenicity and Safety of Diphtheria, Tetanus and Acellular Pertussis (Component) Combined Vaccine (Adsorbed) in 3-month-old InfantsStatus: Recruiting, Estimated PCD: 2025-05-25
Clinical trial
A Randomized, Blinded, Parallel Controlled Phase 3 Clinical Study to Evaluate the Safety and Immunogenicity of the Diphtheria, Tetanus and Three-components Acellular Pertussis Combined Vaccine, Adsorbed in Healthy Infants at the Age of 2 Months and 3 MonthsStatus: Active (not recruiting), Estimated PCD: 2023-09-22
Clinical trial
A Randomized,Blind, Positive-controlled Phase I Clinical Trial to Preliminary Evaluate the Safety of DTcP Vaccine in Healthy Children Aged Between 2 Months and 6 YearsStatus: Completed, Estimated PCD: 2021-10-27